iShares S&P 500 Health Care Sector UCITS ETF (LON:IHCU)

Assets	2.35B
Expense Ratio	0.15%
PE Ratio	24.76
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+27.78%

Volume	25,368
Open	1,033.00
Previous Close	1,034.00
Day's Range	1,031.50 - 1,036.50
52-Week Low	800.25
52-Week High	1,044.35
Beta	0.35
Holdings	68
Inception Date	Nov 20, 2015

About IHCU

iShares S&P 500 Health Care Sector UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the health care sector, which include companies involved in the health care equipment and supplies or provide health care related services, including distributors of health care products, providers of basic health-care services, owners and operators of health care facilities and organizations, and research, development, production, and marketing of pharmaceuticals and biotechnology products. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the S&P 500 Health Care Index, by investing in the stocks of companies as per their weightings in the index. iShares S&P 500 Health Care Sector UCITS ETF was formed on August 22, 2011 and is domiciled in Ireland.

• Asset Class: Equity
• Category: Health Care
• Region: North America
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IHCU
• Provider: iShares
• Index Tracked: S&P 500 CAPPED 35/20 HEALTH CARE NTR

Performance

IHCU had a total return of 27.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.19%.

Top 10 Holdings

60.87% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	15.13%
Johnson & Johnson	JNJ	10.67%
AbbVie Inc.	ABBV	7.65%
Merck & Co., Inc.	MRK	5.94%
UnitedHealth Group Incorporated	UNH	5.55%
Thermo Fisher Scientific Inc.	TMO	3.95%
Amgen Inc.	AMGN	3.42%
Gilead Sciences, Inc.	GILD	3.05%
Abbott Laboratories	ABT	2.91%
Pfizer Inc.	PFE	2.58%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error